EUVIMEDEUVIMED entdecken
Open Access

A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study

Bruno Bohn, Pamela L Lutsey, Weihong Tang, James S Pankow, Faye L Norby, Bing Yu, Christie M Ballantyne, Eric A Whitsel, Kunihiro Matsushita, Ryan T Demmer

Journal of Proteomics · 2023-02 · 272 · 104788

DOI: 10.1016/j.jprot.2022.104788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteomics, 2023-02. Verfasst von Bruno Bohn und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology and Community Health, University of Minnesota School of Public Health, United States of America. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Atherosclerosis, Cardiovascular Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, U.S. Department of Health and Human Services, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Statins are prescribed to reduce LDL-c and risk of CVD. Statins have pleiotropic effects, affecting pathophysiological functions beyond LDL-c reduction. We compared the proteome of statin users and nonusers (controls). We hypothesized that statin use is associated with proteins unrelated to lipid metabolism. METHODS: Among 10,902 participants attending ARIC visit 3 (1993-95), plasma concentrations of 4955 proteins were determined using SOMAlogic's DNA aptamer-based capture array. 379 participants initiated statins within the 2 years prior. Propensity scores (PS) were calculated based on visit 2 (1990-92) LDL-c levels and visit 3 demographic/clinical characteristics. 360 statin users were PS matched to controls. Log2-transformed and standardized protein levels were compared using t-tests, with false discovery rate (FDR) adjustment for multiple comparisons. Analyses were replicated in visit 2. RESULTS: Covariates were balanced after PS matching, except for higher visit 3 LDL-c levels among controls (125.70 vs 147.65 mg/dL; p < 0.0001). Statin users had 11 enriched and 11 depleted protein levels after FDR adjustment (q < 0.05). Proteins related and unrelated to lipid metabolism differed between groups. Results were largely replicated in visit 2. CONCLUSION: Proteins unrelated to lipid metabolism differed by statin use. Pending external validation, exploring their biological functions could elucidate pleiotropic effects of statins. SIGNIFICANCE: Statins are the primary pharmacotherapy for lowering low-density lipoprotein (LDL) cholesterol and preventing cardiovascular disease. Their primary mechanism of action is through inhibiting the protein 3hydroxy-3-methylglutaryl CoA reductase (HMGCR) in the mevalonate pathway of LDL cholesterol synthesis. However, statins have pleiotropic effects and may affect other biological processes directly or indirectly, with hypothesized negative and positive effects. The present study contributes to identifying these pathways by comparing the proteome of stain users and nonusers with propensity score matching. Our findings highlight potential biological mechanisms underlying statin pleiotropy, informing future efforts to identify statin users at risk of rare nonatherosclerotic outcomes and identify health benefits of statin use independent of LDL-C reduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsAtherosclerosisCardiovascular DiseasesHumansCholesterol, LDLProteomicsProteomeCholesterol

Stichwörter der Autor:innen

PleiotropyProteomicsStatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsCholesterol, LDLProteomeCholesterol

Autor:innen und Institutionen

  • Division of Epidemiology and Community Health, University of Minnesota School of Public Health, United States of America.
  • Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, United States of America.
  • Baylor College of Medicine, United States of America.
  • Department of Epidemiology, Gillings School of Public Health and Department of Medicine, University of North Carolina - Chapel Hill, NC, United States of America.
  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, United States of America.
  • Division of Epidemiology and Community Health, University of Minnesota School of Public Health, United States of America. Electronic address: demm0009@umn.edu.

Förderung

  • NHLBI NIH HHS
  • U.S. Department of Health and Human Services
  • National Heart, Lung, and Blood Institute
  • National Institutes of Health

Zitieren

APA

Bohn, B., Lutsey, P. L., Tang, W., Pankow, J. S., Norby, F. L., Yu, B., Ballantyne, C. M., Whitsel, E. A., Matsushita, K., & Demmer, R. T. (2023). A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study. Journal of Proteomics, 272, 104788. https://doi.org/10.1016/j.jprot.2022.104788

Vancouver

Bohn B, Lutsey PL, Tang W, Pankow JS, Norby FL, Yu B, et al. A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study. Journal of Proteomics. 2023;272:104788. doi:10.1016/j.jprot.2022.104788

BibTeX
@article{Bohn2023,
  author = {Bohn, Bruno and Lutsey, Pamela L and Tang, Weihong and Pankow, James S and Norby, Faye L and Yu, Bing and Ballantyne, Christie M and Whitsel, Eric A and Matsushita, Kunihiro and Demmer, Ryan T},
  title = {A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study},
  journal = {Journal of Proteomics},
  year = {2023},
  volume = {272},
  pages = {104788},
  doi = {10.1016/j.jprot.2022.104788}
}
Kostenlos starten →